Search clinical trials for: Tavanex
Total 178 results
-
Shengjing HospitalRecruitingBreast NeoplasmsChina
-
Hebei Medical University Fourth HospitalRecruitingAdvanced Breast Cancer | HER2-positive Breast CancerChina
-
Aspira Women's HealthTerminated
-
Bristol-Myers SquibbTerminated
-
Bristol-Myers SquibbCompletedNon-small Cell Lung CancerCanada, United States
-
University of FloridaRecruitingBreast CancerUnited States
-
Bristol-Myers SquibbTerminated
-
Shanghai Jiao Tong University School of MedicineRecruiting
-
Titan PharmaceuticalsTerminated
-
Titan PharmaceuticalsTerminatedLymphoma, Small Lymphocytic | Leukemia, Lymphocytic, ChronicUnited States
-
University of FloridaPrana TherapeuticsWithdrawn
-
Bristol-Myers SquibbTerminatedNon-small Cell Lung CancerSpain, Belgium, France, Italy, Netherlands, Canada, United Kingdom, United States
-
H. Lee Moffitt Cancer Center and Research InstituteCortice Biosciences, Inc.TerminatedBrain Metastases | Brain Lesions | Generalized Malignancy, PrimaryUnited States
-
Yonsei UniversityRecruitingBreast CancerKorea, Republic of
-
BayerCompletedLymphoma, Non-HodgkinCanada, France, Germany, United States, Netherlands, United Kingdom
-
BayerCompletedBreast Neoplasms | Breast Cancer, MetastaticGermany, Italy, Israel, Poland, Switzerland, United Kingdom, Greece
-
Shanghai Jiao Tong University School of MedicineCSPC Ouyi Pharmaceutical Co., Ltd.; Innovent Biologics, Inc.Not yet recruiting
-
Memorial Sloan Kettering Cancer CenterActive, not recruiting
-
BayerCompletedCarcinoma, Non-Small-Cell LungItaly, Spain, Canada, United States, Germany, Israel
-
Bavarian NordicNational Institutes of Health (NIH)CompletedHIV InfectionsUnited States, Puerto Rico
-
Shanghai Gynecologic Oncology GroupFudan University; Shanghai Zhongshan Hospital; Shanghai Jiao Tong University...CompletedFallopian Tube Cancer | Primary Peritoneal Carcinoma | Bulky Stage IIIC and IV Epithelial Ovarian CancerChina
-
German Breast GroupTerminated
-
BiogenCompleted
-
New Mexico Cancer Care AllianceCompletedSupportive | Ill-defined SitesUnited States
-
Guangdong Provincial People's HospitalRecruitingNeoadjuvant Therapies for HER2+ Breast CancerChina
-
Sun Yat-sen UniversityChengdu Biostar PharmaceuticalsNot yet recruitingBreast Neoplasms | Locally Advanced or Metastatic Breast CancerChina
-
Haukeland University HospitalRecruitingEndometrial CancerNorway, Netherlands, Poland
-
Eli Lilly and CompanyCompletedNon-Small-Cell Lung CarcinomaUnited States
-
Centre Hospitalier Universitaire de BesanconCompletedMetastatic Cancer | HER2-positive Gastric Cancer | Docetaxel | TrastuzumabFrance
-
Bavarian NordicUS Army Medical Research Institute of Infectious DiseasesCompleted18-42 Year Old Healthy Vaccinia-naïve SubjectsKorea, Republic of
-
Ruijin HospitalRecruitingHER2-negative Advanced Gastric CancerChina
-
Azienda Ospedaliero-Universitaria CareggiCompletedMetastatic Prostate Cancer | Elderly PatientsItaly
-
Bavarian NordicCompleted
-
Hebei Medical University Fourth HospitalNot yet recruiting
-
BiogenCompletedMultiple SclerosisUnited States
-
Hoffmann-La RocheCompletedBreast CancerUnited Kingdom, Spain, Australia, Sweden
-
Hoffmann-La RocheCompletedBreast CancerAustralia, France, Germany, Israel, Italy, Spain, Sweden, China, Hong Kong, Canada, Switzerland, Portugal, Russian Federation, Czech Republic, Brazil, Austria, Estonia, Slovakia, Netherlands, Bulgaria, Hungary, Latvia, Mexico, Slovenia, United Kingdom and more
-
BiogenCompletedMultiple SclerosisBelgium
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingFirst-line Treatment | HER2-positive Metastatic Breast CancerChina
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Clinical Isolated Syndrome (CIS)Czech Republic, Switzerland
-
Bristol-Myers SquibbActive, not recruitingAdvanced Solid Tumors | Non-small Cell Lung CancerUnited States, Italy, Australia, Poland, Spain
-
Janssen Research & Development, LLCCompleted
-
Trio Medicines Ltd.BiogenCompleted
-
PfizerCompletedAdenocarcinomaUnited States
-
Second Affiliated Hospital, School of Medicine,...Sun Yat-sen University; Peking University International Hospital; Zhejiang UniversityNot yet recruitingHER2-positive Breast Cancer | Brain MetastasesChina
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedRelapsing-remitting Multiple SclerosisUnited States, Germany
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedRelapsing-remitting Multiple SclerosisUnited States, Germany
-
Hoffmann-La RocheCompletedBreast CancerItaly, Spain, China, Taiwan, Russian Federation, Canada, Germany, Austria, Hungary, Belgium, Australia, Brazil, Mexico, Poland, Panama